Rogan said resveratrol works by inducing an enzyme called quinone reductase, which reduces the estrogen metabolite back to inactive form. By making estrogen inactive, resveratrol decreases the associated risk.
The current study was conducted in laboratory cultures, and will need to be confirmed in larger human trials, Rogan said.
'/>"/>
| Contact: Jeremy Moore Jeremy.moore@aacr.org 267-646-0557 American Association for Cancer Research Source:Eurekalert |